Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 13/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.43 |
| ▸ | CXCR1 | P25024 | 4/20 | 0.43 |
| ▸ | CXCR2 | P25025 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.43 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 8/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7076065 | 0.95 | PTGS2 (0.45) | PTGS2PTGS1CXCR1CXCR2LMNA | |
| SCHEMBL7080519 | 0.80 | NPC1 (0.46) | LMNAMAPTSMN1; SMN2ALDH1A1CYP3A4 | |
| SCHEMBL1001487 | 0.80 | PTGS2 (0.44) | PTGS2PTGS1CXCR1CXCR2LMNA | |
| SCHEMBL360725 | 0.79 | PTGS1 (0.59) | PTGS2PTGS1CXCR1CXCR2LMNA | |
| SCHEMBL8579553 | 0.79 | PTGS1 (0.59) | PTGS2PTGS1CXCR1CXCR2LMNA | |
| SCHEMBL5846200 | 0.79 | PTGS2 (0.54) | PTGS2PTGS1CXCR1CXCR2LMNA | |
| SCHEMBL8960142 | 0.79 | PTGS2 (0.54) | PTGS2PTGS1CXCR1CXCR2LMNA | |
| SCHEMBL29994454 | 0.78 | LMNA (0.46) | LMNAMAPTKDM4EALDH1A1CYP3A4 | |
| Hydrochloric Acid SCHEMBL1177638 | 0.78 | PTGS1 (0.57) | PTGS2PTGS1CXCR1CXCR2LMNA | |
| SCHEMBL2818028 | 0.77 | PTGS2 (0.61) | PTGS2PTGS1CXCR1CXCR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108003896-B | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | 奇美实业股份有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-111116912-A | Polyimide resin, preparation method thereof and method for preparing polyimide film/cross-linked polyimide film by using polyimide resin | 山东华夏神舟新材料有限公司 | 2020-05-08 | — | — | CN | disclosed |
| CN-105694914-A | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-105694913-A | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-105647181-A | Composition for flexible substrate and flexible substrate | 奇美实业股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-105567258-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly | CHI MEI CORP | 2016-05-11 | — | — | CN | disclosed |
| CN-105567257-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-05-11 | — | — | CN | disclosed |
| CN-105482830-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-04-13 | — | — | CN | disclosed |
| CN-105462598-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | CHI MEI CORP | 2016-04-06 | — | — | CN | disclosed |
| CN-105316004-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-02-10 | — | — | CN | disclosed |
| CN-105087019-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2015-11-25 | — | — | CN | disclosed |
| CN-105087020-A | Liquid crystal alignment agent and application thereof | CHI MEI CORP | 2015-11-25 | — | — | CN | disclosed |
| CN-105038818-A | Liquid crystal alignment agent and application thereof | CHI MEI CORP | 2015-11-11 | — | — | CN | disclosed |
| US-7868135-B2 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | BIOWEST THERAPEUTICS INC. (CA) | 2011-01-11 | — | — | US | disclosed |
| EP-2147925-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | MIGENIX INC. (CA) | 2010-01-27 | — | — | EP | disclosed |
| US-20080171783-A1 | COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE | MIGENIX INC. (CA) | 2008-07-17 | — | — | US | disclosed |
| EP-1910279-A2 | NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF | MIGENIX INC. (CA) | 2008-04-16 | — | — | EP | disclosed |
| US-20070021434-A1 | NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF | MIGENIX INC. (CA) | 2007-01-25 | — | — | US | disclosed |
| WO-2007002639-A2 | NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF | MIGENIX INC. (CA) | 2007-01-04 | — | — | WO | disclosed |
| US-20050153876-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | MIGENIX INC. (CA) | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021434-A1 | NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF | HAVCR2, ADAR, NSUN2 | PTGS2 4421/4885PTGS1 4248/4885CXCR1 850/4885 |
| US-20050153876-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | NRDC, NOD2, NGLY1 | PTGS2 3443/4885PTGS1 3011/4885CXCR1 571/4885 |
| US-20080171783-A1 | COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE | POLQ, POLI, POLH | PTGS2 2742/4885PTGS1 2224/4885CXCR1 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.